Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

The mice model technologies market offers significant opportunities driven by advancements in genetic engineering, particularly CRISPR/Cas9, fueling drug discovery in oncology, neurobiology, and ...

Transferring one species to another is how to create genetically modified organisms, or GMOs. This creates something not ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.

A study reveals how RNA modifications regulate the transformation of stem cells into retinal cells. The protein METTL3, which ...

The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...

Pumpkins, squash, zucchini and their relatives accumulate soil pollutants in their edible parts. A Kobe University team has ...

We are thrilled to welcome Matt to our leadership team,” said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. “Business development has been – and will continue to be – a core pillar of ...